Profile picture

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)
Membership: FESC Member
Follow
Biography
Dr. Darren K. McGuire, M.D is a general cardiologist in the Division of Cardiology at the University of Texas Southwestern Medical Center, and a clinical trialist with expertise in large-scale CV outcomes trial design and execution, and drug registration/regulation, with a focus on diabetes and cardiovascular disease. He is a Distinguished Teaching Professor of Medicine with Tenure, is the Jere H. Mitchell, M.D. Distinguished Chair in Cardiovascular Science and is the Lead Physician of the Parkland Health and Hospital System Cardiology Clinics. Dr. McGuire participated in numerous international cardiovascular clinical outcomes trials, including T2DM, obesity, and lipid trials. Dr. McGuire is a previous member of the FDA Cardiovascular and Renal Drugs Advisory Committee. He is Deputy Editor of Circulation, Senior Editor of Diabetes and Vascular Disease Research, and co-editor of the textbook: Diabetes in Cardiovascular Disease: A Companion to Braunwald’s Heart Disease.
Logo ESC

Contributor content

A cross-specialty focus – Who are the appropriate patients for SGLT2is?
Session
A cross-specialty focus – Who are the appropriate patients for SGLT2is?
3 September 2019
Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?
Session
Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?
2 September 2019
Five things cardiologists should know about diabetes
Session
Five things cardiologists should know about diabetes
27 August 2018
Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease
Session
Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease
28 August 2017
Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin
Session
Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin
27 August 2017

ESC 365 is supported by